Cassava Sciences (SAVA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov13

Cassava Sciences released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2237 (forecast USD -0.27)

04:00

Cassava Sciences released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 0 and EPS of USD -1.6286

04:00

Oct2

Cassava Sciences Inc. COO and Legal Officer Acquires Company Stock

20:46

Aug15

Cassava Sciences released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.92

03:00

Cassava Sciences released FY2025 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 0 and EPS of USD -1.4005

03:00

Jun30

Cassava Sciences Inc. Plans Clinical Study of Simufilam for TSC-Related Epilepsy

11:00

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -10.81 M, EPS -0.2237

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -44.22 M, EPS -0.92

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -23.4 M, EPS -0.4849

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More